Back to my company list

Innoplexus

The AI engine Fit Assessment

Beta

INNOPLEXUS effectively leverages machine learning to discover patterns and expand therapeutics, while also focusing on biomarker identification for personalized medicine.

Blurb

Innoplexus™ - AI and Blockchain powered data analytics solutions help the life science industry gain real-time access to relevant insights

HQ Location

Eschborn (Germany)

Founded

2011

Employees

201 - 500

Total funding raised

Not available

Last Funding Event

Series C, April 24, 2019

Smart insights

  • Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
  • Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
  • 6m headcount growth: 25%
  • 1Y headcount growth: 94%
  • Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
  • Biomarker Identification

Developer of advanced artificial intelligence and blockchain technology platform designed to support all stages of drug development from pipeline to market. The company's platform identifies and extracts structured and unstructured life science data by scanning the World Wide Web and merges it with enterprise and third-party data in an ongoing, real-time process, enabling life sciences organizations to generate actionable insights across pre-clinical, clinical, regulatory and commercial stages of drug development using data analytics.